Neil F. McFarlane, President and CEO: Zevra Therapeutics ZVRA Sell · Filed 25/10/10

Trade details

Type: Insider sale
Amount: $210,990
Shares · price: 19,500 sh · $10.82 a share
Held after: 222,016 sh
Stock: Zevra Therapeutics ZVRA
Person: Neil F. McFarlanePresident and CEO
Trade date: 25/10/10
Filed: 25/10/10
Days to filing: 0 days

Sold 8.1% of holdings

Share of holding sold: 8.1%

Zevra Therapeutics trades, last 26 weeks

What else happened in Zevra Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/10~25/11/09

Neil F. McFarlane's recent trades

Neil F. McFarlanePresident and CEO
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 plan
Zevra Therapeutics
ZVRA
$125.2K
14,625 sh
$125.2K
Filed 02/10
Traded 02/09
Neil F. McFarlanePresident and CEO
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 plan
Zevra Therapeutics
ZVRA
$853.6K
91,000 sh
$853.6K
Filed 02/02
Traded 02/02
Neil F. McFarlanePresident and CEO
Planned sale10b5-1 planZevra Therapeutics
Planned sale10b5-1 plan
Zevra Therapeutics
ZVRA
$950.6K
105,625 sh
$950.6K
Filed 02/02
Traded 02/02
Neil F. McFarlanePresident and CEO
Planned sale10b5-1 planZevra Therapeutics
Planned sale10b5-1 plan
Zevra Therapeutics
ZVRA
$211K
19,500 sh
$211K
Filed 25/10/10
Traded 25/10/10
Neil F. McFarlanePresident and CEO
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 plan
Zevra Therapeutics
ZVRA
$481.6K
61,273 sh
$481.6K
Filed 25/02/14
Traded 25/02/13